Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coding and billing issues in the vascular laboratory.

R M Zwolak1

  • 1Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

Seminars in Vascular Surgery
|September 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Danazol and limb-threatening arterial thrombosis: two case reports.

Journal of vascular surgery·2001
Same author

Results of endovascular superficial femoral endarterectomy.

Journal of vascular surgery·2001
Same author

Early results of infragenicular revascularization based solely on duplex arteriography.

Journal of vascular surgery·2001
Same author

Pedal branch artery bypass: a viable limb salvage option.

Journal of vascular surgery·2000
Same author

Can duplex ultrasound replace arteriography in screening for mesenteric ischemia?

Seminars in vascular surgery·2000
Same author

Fate of the contralateral leg after infrainguinal bypass.

Journal of vascular surgery·1998
Same journal

Management decisions for patients with chronic limb-threatening ischemia in 2026.

Seminars in vascular surgery·2026
Same journal

A critical analysis of the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) and the European Carotid Surgery Trial (ECST)-2.

Seminars in vascular surgery·2026
Same journal

Operationalizing patient and stakeholder engagement in high-acuity trials: Lessons from IMPROVE-AD.

Seminars in vascular surgery·2026
Same journal

Lost to follow-up: A narrative review of socioeconomic, psychosocial, and systemic barriers to aortic dissection surveillance.

Seminars in vascular surgery·2026
Same journal

Regulatory oversight, innovation, and access in aortic dissection care: The evolving roles of the US Food and Drug Administration and Centers for Medicare & Medicaid Services.

Seminars in vascular surgery·2026
Same journal

What is the best thoracic endovascular aortic repair landing zone for Type B aortic dissection?

Seminars in vascular surgery·2026
See all related articles

Noninvasive vascular testing offers a safe, accurate, and cost-effective alternative to contrast imaging. However, challenges from the Health Care Financing Administration (HCFA) threaten the quality of these vital vascular ultrasound examinations.

Area of Science:

  • Vascular Medicine
  • Medical Imaging Technology
  • Health Economics

Background:

  • Noninvasive vascular testing emerged as a safer, more affordable alternative to contrast venography and arteriography.
  • Duplex ultrasound studies provide accurate vascular disease evaluation at a significantly lower cost than contrast procedures.
  • Despite proven benefits, noninvasive vascular testing faces persistent challenges from healthcare financing bodies.

Purpose of the Study:

  • To review a decade of payment issues impacting noninvasive vascular laboratories.
  • To highlight inequities and problems threatening the quality of vascular ultrasound technology.
  • To analyze Medicare Part B payment challenges, including denials, supervision, and RVU calculations.

Main Methods:

  • Review of payment policies and challenges over the past ten years.

Related Experiment Videos

  • Focus on Medicare Part B payment issues, which constitute the majority of noninvasive study payments.
  • Inclusion of analysis on Health Care Financing Administration (HCFA) payment calculations, including relative value units (RVUs).

    • Main Results:

    • Noninvasive vascular testing is safe, accurate, and cost-effective, preventing complications associated with contrast injections.
    • Financing agencies, particularly HCFA, have consistently reduced payments and imposed problematic requirements on vascular laboratories.
    • Payment denials, supervision issues, and zero work pool problems negatively impact the quality of care.

    Conclusions:

    • Noninvasive vascular testing is a crucial, high-quality diagnostic tool that should not be undermined by payment disputes.
    • Urgent attention is needed to address the financial and regulatory challenges faced by vascular laboratories.
    • Ensuring adequate reimbursement and appropriate oversight is vital for maintaining the quality and accessibility of noninvasive vascular services.